From: SARS-CoV-2: characteristics and current advances in research
Differences | SARS-CoV | SARS-CoV-2 | |
---|---|---|---|
Virological characteristics | Classification | the SARS cluster | bat-like coronavirus cluster |
Amino acid composition of ORF8b | aggregation motif VLVVL in SARS-CoV ORF8b | no functional domain or motif in SARS-CoV-2 ORF8b | |
Number of amino acids encoding 8b protein | 84 | 121 | |
Number of amino acids encoding 3b protein | 154 | 67 | |
ORF3b protein | / | having four helices | |
8a protein | existing | nonexistent | |
Epidemiological characteristics | sources of infection | wild animals, patients | wild animals, patients and asymptomatic infector |
intermediate host | civet | Pangolin? | |
routes of transmission | respiratory tract transmission, contact transmission | respiratory tract transmission, contact transmission, may be including digestive tract transmission?, urine? and mother-to-child transmission? | |
susceptible populations | susceptibility to the entire population, mainly in adults | susceptibility to the entire population | |
Infectiousness(R0) | 2–3 | ||
crude death rate | 11% | ||
Clinical characteristics | respiratory symptoms | High fever, cough are common | low fever, and temperature does not rise in some cases, cough |
Gastrointestinal symptoms | Common (diarrhea is rare) | uncommon; can be the initial symptoms | |
cardiovascular symptoms | / | palpitations and chest pain can be the initial symptoms | |
concominant diseases | including cardio-cerebrovascular diseases, hypertension, diabetes | higher frequency including cardio-cerebrovascular diseases, hypertension, diabetes | |
imaging features | pulmonary consolidation and exudation | ground glass opacity, pulmonary consolidation and exudation | |
pathological characteristics | lung | pulmonary edema accompanied by exudation of fibrin; Pulmonary fibrosis is a common characteristic. | pulmonary edema accompanied by exudation of fibrin; mainly mucus exudation; thrombi within peripheral small vessels in lungs. |